Company news
Paxman Ab (OMXSTO:PAX) news
Every Paxman Ab press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Paxman : Interim Report Q1 2026
May 21, 2026
PAXMAN publishes its interim report for Q1 2026
May 21, 2026
Paxman publishes the company’s annual report for 2025
April 24, 2026
NOTICE OF ANNUAL GENERAL MEETING IN PAXMAN AB (publ)
April 20, 2026
Paxman : Interim Report Q4 2025 DIGITAL
February 27, 2026
PAXMAN publishes year-end report as of 31 December 2025
February 27, 2026
Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy
February 20, 2026
PAXMAN announces 510k Submission to the U.S. Food and Drug Administration (FDA) for the Paxman Cryocompression Device to Prevent Chemothe...
December 31, 2025
Paxman announces that CMS has finalized the 2026 Medicare payment rates for mechanical scalp cooling under the Hospital Outpatient and Ph...
November 24, 2025
PAXMAN publishes its interim report for Q3 2025
November 14, 2025
Paxman announces progress of its Clinical Trial for Chemotherapy Induced Peripheral Neuropathy, with latest data presented at EONS18 Conf...
October 20, 2025
PAXMAN announces the acceptance of the Paxman Limb Cryocompression System (PLCS) into the FDA’s Safer Technologies Program (STeP).
October 17, 2025
Paxman : Kvartalsrapport Q2 2025
August 20, 2025
PAXMAN publishes its interim report for Q2 2025
August 20, 2025
Outpatient Prospective Payment System (OPPS) Proposed Rule Assigns 2026 Payment Rates for Mechanical Scalp Cooling
July 16, 2025